Decades-Old Anonymized Medical Data May Cause AI Misdiagnoses Now A Germany-UK research collaboration warns that anonymized patient records included in medical datasets decades ago can cause AI systems to treat a 2026 patient as their earlier self, potentially producing false diagnoses of recurrence or masking new conditions, according to a new paper posted at arxiv.org/pdf/2609.17223. The paper cites Germany's national breast cancer screening program, which uses an AI model trained on 1.2 million mammograms from the same screening population it serves, with comparable deployment underway in the United Kingdom and Sweden, and notes the EU AI Act requires training data to reflect the geographical and contextual setting of intended use. The researchers attribute the elevated risk to data localization, since limiting training data to a national pool increases memorization of individual records. Anderson's Angle https://www.unite.ai/series/andersons-angle/ Decades-Old Anonymized Medical Data May Cause AI Misdiagnoses Now Add Unite.AI to your preferred sources on Google https://www.google.com/preferences/source?q=unite.ai According to a new research collaboration between Germany and the UK, anonymized patient records that were included in medical datasets even decades ago may cause AI systems trained on them to recognize the real patient’s characteristics years later – and treat a 2026 patient as if it was still 2012 or whichever year their anonymized patient data was first included in the dataset/s . This could mean, for instance, that a patient who was recorded as undergoing cancer treatment 20 years ago, and who subsequently went into long-term remission, could now be treated by the AI system in the context of their older, cancer-afflicted self – logically even increasing the chances of a false diagnosis of recurrence. Conversely, if the 2012 version of that patient’s data reflected perfect health in routine check-ups, this optimistic standpoint could potentially be imposed onto the older, current version of the patient, masking the detection of new conditions or issues that may need treating. Curbing ‘Data Immigration’ The scenario is made more probable by various national and regional directives recommending that patient data for such purposes should ideally be taken from the country in which systems derived from it are intended to be used, which ‘localizes’ the patient pool in the datasets, and notably increases the chance of this kind of undetected de-anonymization event. By inference, limiting the amount of data available to only a national dataset increases the chance of memorization https://www.unite.ai/llms-memory-limits-when-ai-remembers-too-much/ :~:text=Balancing%20Memory%20and%20Generalization%20in%20LLMs,-To – the possibility that the model will see the same data so many times during training that it becomes ‘fixated’ on these over-learned patterns. Conversely, the larger and more diverse a dataset is, the more likely it is that it will generalize https://archive.is/XWMt9 to unseen data after training, instead of memorizing specific data-points or configurations. However, adding ‘foreign’ medical data risks to introduce evidence of national health trends and idiosyncrasies that would not apply in the country in which the trained model is being deployed; in this respect, as the new paper https://arxiv.org/pdf/2609.17223 concedes, a certain amount of memorization is appropriate and useful, since it helps the model to work within the likeliest general medical characteristics of a particular population. The paper states : ‘ When models are deployed prospectively, memorisation creates a specific and under-appreciated risk. Because a patient’s records are highly self-similar over time, a future record may act as a partial cue for a memorised historical record, shifting the model’s predictions towards a patient’s previous health state. This is not a hypothetical scenario. Medical AI models are routinely deployed on the same population from which their training data were sourced. ‘For example, Germany’s national breast cancer screening program https://www.nature.com/articles/s41591-024-03408-6 uses